North American Custom Laboratories, LLC dba PT-141 (Bremelanotide Acetate) 10 mg/mL (2 mL) recall — FDA D-0780-2022
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.